Topic: MedTech

Precision Spine has announced the launch of the Dakota ACDF standalone system for the treatment […]

The ANT-X system helps clinicians perform safe and accurate percutaneous needle placement.

Camber Spine has initiated the full US launch of its SPIRA-P posterior lumbar spacer and […]

This comes just a month after news broke Nanox was set to acquire Zebra Medical Vision.

The Medical Alley Association announced today that it appointed Roberta Dressen as its new president […]

GE Healthcare (NYSE:GE) announced today that it entered into an agreement to acquire BK Medical for $1.45 billion. […]

NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its […]

Medtronic (NYSE:MDT) announced today that it enrolled the first patient in a study for its Braive […]

Nuwellis (NSDQ:NUWE) announced today that it received CE mark approval for its 24-hour blood circuit set […]

It’s the latest in a series of milestones for the startup, which has picked up 510(k) clearance for its image viewer, raised more than $220 million and partnered with Philips and Quest Diagnostics in recent years.

Boston Scientific’s proposed acquisition of Devoro Medical comes a few weeks after Abbott Laboratories announced it would acquire Walk Vascular, another player in the thrombectomy space.

An estimated 1.5 billion women have not been tested in the past year for critical […]

Abbott (NYSE:ABT) today announced U.S. FDA approval of its Portico with FlexNav TAVR system. The […]

joimax has received FDA clearance to market the EndoLIF Delta-Cage and EndoLIF DoubleWedge-Cage—both of which are […]

Boston Scientific (NYSE:BSX) today touted data from a Phase 3 clinical trial of its TheraSphere […]

Spinal Elements has announced the full commercial launch of the Luna XD multi-expandable lumbar interbody fusion […]

The startup, which has a cleared device to reduce tremors using electrical stimulation, recently shared the results of a post-market analysis showing device use and efficacy.

With the results of a recent trial, Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalizations in patients with heart failure. It’s also hoping to win over national coverage from CMS.

WALTHAM, Mass. & HONG KONG–(BUSINESS WIRE)–Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, […]

The Alfred E. Mann Foundation for Scientific Research (AMF) today announced the sale of intellectual […]

Stryker (NYSE:SYK) announced today that its trauma & extremities division launched its Citrelock tendon fixation device […]

InTRAvent has announced FDA 510(k) clearance of its Solopass system for assisting frontal placement of […]

Zimmer Biomet (NYSE:ZBH) announced today that the planned spinoff of its spine and dental businesses will […]

Centinel Spine has announced the first international implantation of the 3D-printed porous titanium FLX platform. […]

The device can help reduce injuries that sonographers get from operating large diagnostic machines while producing 3D diagnostic outputs.

Xenter today announced that it has appointed Mark Turco as president of its Xenter Medical […]

NeuroOne Medical Technologies (NMTC) announced that it received FDA 510(k) clearance for its Evo sEEG electrode […]

The Chelmsford, MA-based company is acquiring Itamar Medical for about $538 million.

Nectero Medical announced today that it closed a $19.5 million Series C funding round led by […]

The telehealth giant struck a partnership with Proximie, which uses augmented reality to let clinicians virtually “scrub in” to operating rooms. 

Medtronic’s clinical study of its Symplicity Spyral renal denervation system for hypertension is likely to […]

Corin Group announced today that it appointed former Medtronic executive Jacob Paul as its new CEO. […]

ResMed (NYSE:RMD) is touting data highlighting the use of PAP therapy and its connection to potentially […]

Novocure (NSDQ:NVCR) announced today that the FDA granted breakthrough designation for its NovoTTF-200T liver cancer treatment […]

Boston Scientific recently announced FDA clearance of the EXALT Model B single-use bronchoscope, intended for […]

Boston Scientific has announced the European launch of FAST—a new fast-acting sub-perception therapy that the […]

KALAMAZOO, Mich., Sept. 7, 2021 /PRNewswire/ — Stryker announced today that it has completed the acquisition of […]

Eli Lilly (NYSE:LLY) announced today that it will commit nearly $1 million over the next three […]

NeuroOne Medical Technologies—a company focused on improving surgical care options and outcomes for patients with […]